Scholars Central

Short communicationPublished 28 Mar 2025

Pharmacological Advances in Analgesics for Chronic Pain Management

Authors: Ayla Demir

Department of Clinical Medicine, Istanbul University, Istanbul, Turkey

Journal of Pain & Relief

Volume 14 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic pain affects millions of individuals globally and significantly impacts quality of life, work productivity, and mental health. Managing chronic pain presents substantial clinical challenges due to the complexity of its pathophysiology and the limitations of current therapies. While opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) have long been the cornerstone of pharmacological pain management, their side effects, potential for dependence, and inadequate efficacy in certain chronic conditions have necessitated the development of novel analgesics. This article provides an overview of recent pharmacological advances in chronic pain management, including next-generation NSAIDs, ion channel modulators, monoclonal antibodies, cannabinoid-based agents, and combination therapies. These innovations aim to address limitations of traditional analgesics, reduce side effects, and enhance therapeutic specificity. Despite ongoing challenges, these advances mark significant progress toward a more personalized and effective approach to chronic pain relief.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pain & Relief
  • SubjectPharmaceutical Sciences
  • SubjectAnaesthesia & Pain
  • BylineArticles whose byline prints “Ayla Demir”